Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

US Patent 7511057 · Granted Mar 31, 2009

Estimated economic value: $563,080,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BRM/BRG1 inhibitors and uses thereof2025
Fused tricyclic compounds useful as anticancer agents2025
Compounds and uses thereof2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2025
Bicyclic-fused heteroaryl or aryl compounds2025
Synthesis of substituted furans2024
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2024
Methods and compounds for treating disorders2023
Bicyclic-fused heteroaryl or aryl compounds2023
Synthesis of substituted furans2023
Compounds and uses thereof2022
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2022